A Perspective on Unintentional Fragments and their Impact on the Dark Metabolome, Untargeted Profiling, Molecular Networking, Public Data, and Repository Scale Analysis.
In/post-source fragments (ISFs) arise during electrospray ionization or ion transfer in mass spectrometry when molecular bonds break, generating ions that can complicate data interpretation. Although ISFs have been recognized for decades, their contribution to untargeted metabolomics - particularly in the context of the so-called “dark matter” (unannotated MS or MS/MS spectra) and the “dark metabolome” (unannotated molecules) - remains unsettled. This ongoing debate reflects a central tension: while some caution against overinterpreting unidentified signals lacking biological evidence, others argue that dismissing them too quickly risks overlooking genuine molecular discoveries. These discussions also raise a deeper question: what exactly should be considered part of the metabolome? As metabolomics advances toward large-scale data mining and high-throughput computational analysis, resolving these conceptual and methodological ambiguities has become essential. In this perspective, we propose a refined definition of the “dark metabolome” and present a systematic overview of ISFs and related ion forms, including adducts and multimers. We examine their impact on metabolite annotation, experimental design, statistical analysis, computational workflows, and repository-scale data mining. Finally, we provide practical recommendations - including a set of dos and don’ts for researchers and reviewers - and discuss the broader implications of ISFs for how the field explores unknown molecular space. By embracing a more nuanced understanding of ISFs, metabolomics can achieve greater rigor, reduce misinterpretation, and unlock new opportunities for discovery.
Authors
- Wenyun Lu (ORCID: https://orcid.org/0000-0003-1787-2617)
- Yasin El Abiead (ORCID: https://orcid.org/0000-0003-4392-7706)
- Gary J. Patti (ORCID: https://orcid.org/0000-0002-3748-6193)
- Adriano Rutz (ORCID: https://orcid.org/0000-0003-0443-9902)
- Óscar Yanes (ORCID: https://orcid.org/0000-0003-3695-7157)
- Shipei Xing (ORCID: https://orcid.org/0000-0001-6227-6959)
- Pieter C. Dorrestein (ORCID: https://orcid.org/0000-0002-3003-1030)
- Tito Damiani (ORCID: https://orcid.org/0000-0002-4616-900X)
- Nicola Zamboni (ORCID: https://orcid.org/0000-0003-1271-1021)
- Ipsita Mohanty (ORCID: https://orcid.org/0000-0001-9194-5795)
- Vincent Charron-Lamoureux
Institutions
- Princeton University (US)
- Washington University in St. Louis (US)
- Instituto de Salud Carlos III (ES)
- ETH Zurich (CH)
- University of California San Diego (US)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Institut de Recerca Biomèdica Catalunya Sud (ES)
- Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry (CZ)
- Universitat Rovira i Virgili (ES)
- University of Montana (US)
Publication Details
- Journal
- ChemRxiv
- Published
- 2025-08-22
- DOI
- https://doi.org/10.26434/chemrxiv-2025-l6pg7
- Citations
- 1
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- National Science Foundation
- European Commission
- Generalitat de Catalunya
- National Institutes of Health
- University of California, San Diego
- Biotechnology and Biological Sciences Research Council
- European Regional Development Fund
- Agencia Estatal de Investigación